TABLE 3.
Achieved HbA1c <7% (N = 219) |
Did Not Achieve HbA1c <7% (N = 200) |
Adjusted HR* (95% CI) |
|
---|---|---|---|
N (%) | N (%) | ||
At a clinic with an endocrinologist on staff (yes vs. no) | 161 (73.5%) | 123 (61.5%) | 1.45 (1.03 to 2.04) |
Treatment for diabetes at the clinic | |||
Clinic treats most patients with DM at the HIV clinic but does refer some patients to another clinic within the institution | 63 (28.8%) | 78 (39.0%) | Ref |
Clinic treats most patients with DM at the HIV clinic and does not refer patients to another clinic within the institution | 67 (30.6%) | 36 (19.5%) | 1.77 (1.20 to 2.61) |
Clinic does not treat most patients with DM at the HIV clinic but refers most patients to another clinic within the institution | 89 (40.6%) | 83 (41.5%) | 1.61 (0.97 to 2.69) |
At a clinic with a diabetes education program (yes vs. no) | 133 (60.7%) | 121 (60.5%) | 1.33 (0.94 to 1.88) |
At a clinic with a weight management program (yes vs. no) | 120 (54.8%) | 118 (59.0%) | 1.23 (0.86 to 1.75) |
At a clinic with a nutritionist on staff (yes vs. no) | 128 (58.5%) | 122 (61.0%) | 1.24 (0.88 to 1.73) |
At a clinic with a smoking cessation program (yes vs. no) | 163 (74.4%) | 142 (71.0%) | 1.34 (1.03 to 1.75) |
At a clinic with an on-site pharmacy (yes vs. no) | 184 (84.0%) | 139 (69.5%) | 1.60 (0.98 to 2.62) |
At a clinic with urgent care services (yes vs. no) | 200 (91.3%) | 155 (77.5%) | 1.99 (0.98 to 4.04)‡ |
At a clinic with physician assistants on staff (yes vs. no) | 73 (33.3%) | 48 (24.0%) | 1.15 (0.82 to 1.59) |
At a clinic with nurse practitioners on staff (yes vs. no) | 133 (60.7%) | 111 (55.5%) | 0.91 (0.58 to 1.43) |
Size of HIV clinic (over 1000 patients vs. 1000 or less patients) | 182 (83.1%) | 153 (76.5%) | 1.16 (0.80 to 1.69) |
Bold indicates significant at the P<0.05 level.
Italic values indicates P<0.1.
Each point estimate reported in this table is the aHR for the listed clinic-level variable included as the only clinic-level variable in a model adjusted for the following individual-level variables: age, race/ethnicity, sex at birth, baseline HbA1c value, diabetes diagnosis at enrollment into the DC Cohort, use of diabetic medications (time-updated), HIV duration, and diagnosis of hypertension at start of observation.